|
The Fight Against Aging
Quincy Bioscience is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat the diseases of aging. The company's products focus on alleviating the consequences of impaired calcium homeostasis - the imbalance of calcium ions commonly thought to be related to neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Quincy Bioscience is set apart by its cutting-edge applications of the calcium-binding protein apoaequorin, which is breaking new ground in the fight against neuronal degeneration.
|
|
|
Quincy Bioscience is dedicated to fighting aging on several fronts. In addition to our pharmaceutical aspirations
we have developed a novel dietary supplement using our patent-pending technology. Our first supplement, Prevagen®,
is now available nationwide in health food stores and Rite-Aid chain drug stores. The only supplement from a jellyfish,
Prevagen® keeps brain cells alive longer. * Our research shows a 28-55% reduction in cellular death when treated with the
jellyfish compound within Prevagen®. Prevagen® was developed by Quincy Bioscience and is the first supplement to address
aging through the restoration of calcium-binding proteins. For more information please visit our website at
www.prevagen.com.
|
Recent News about Quincy Bioscience
October 15, 2008: Jellyfish Protein Shows Potential to Help with Memory.
October 13, 2008: Nobel Prize-winning jellyfish research brings possible Alzheimer’s cure into view.
June 2, 2008: Pro football legend and world champion puts a face on protecting brain cells and fighting the diseases of aging.
January 17, 2008: Are Jellyfish the Lost Link to the Fountain of Youth?
September 1, 2007: Jellyfish Supplement Backed by Science Fights the Process of Aging
August 26, 2007: Talk 650 KSTE - Mark Underwood appears on The Wide World of Health
May 24, 2007: NBC - Jellyfish helping prevent injury from strokes
|